Treatment of Progressive Multifocal Leukoencephalopathy Associated with Natalizumab
Werner Wenning(Ortenau Klinikum), Ralf Gold(St. Josef-Hospital), Aiden Haghikia(Medizinische Hochschule Hannover), David B. Clifford(Washington University in St. Louis), Jörg Laubenberger(University Medical Center Freiburg), Peter F. Behrens(Ortenau Klinikum), Andrew Chan(University of Bern)
Cited by 178
Related Papers
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
|Brain|2011|1.2k
Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine
|Immunity|2015|919
Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism
|Cell|2020|627
Progressive multiple sclerosis: from pathophysiology to therapeutic strategies
|Nature Reviews Drug Discovery|2019|456